Help Build the Cannabis Safety Resource Library

Research examining how limited legal access, geographic disparities, prohibition, criminalization, and reliance on unregulated markets affect patient and consumer safety, healthcare outcomes, product quality, and public health.

Evaluations and case studies of federal, state, local, tribal, and international approaches to cannabis safety, including regulatory models, public education campaigns, surveillance systems, harm-reduction strategies, enforcement approaches, and other efforts intended to reduce risk.

Research on the health effects of pesticides, heavy metals, microbial contamination, residual solvents, adulterants, additives, and other contaminants that may be present in cannabis products.

Research and reports examining cannabis laboratory standards, testing requirements, laboratory accreditation, sampling practices, testing variability, potency accuracy, homogeneity testing, contaminants, proficiency testing, and differences among state programs.

Research evaluating whether product recalls, manufacturing standards, testing requirements, labeling rules, track-and-trace systems, inspections, and other regulatory tools effectively identify hazards and protect consumers.

Research examining interactions between cannabis or cannabinoids and prescription drugs, over-the-counter medications, supplements, alcohol, and other substances, including potential effects on metabolism, efficacy, and adverse events.

Research examining cannabis and cannabinoid exposure during pregnancy and breastfeeding, including maternal health, fetal and infant outcomes, clinical guidance, risk communication, and areas where evidence remains limited or contested.

Research on cannabis use among older adults, including therapeutic use, changing metabolism, fall risk, cognition, dosing considerations, medication interactions, and other issues particularly relevant to aging populations.

Research examining cannabis and cardiovascular health, including heart rate, blood pressure, arrhythmias, vascular health, cardiovascular events, routes of administration, dose, and potential differences among patient populations.

Research examining the causes, prevalence, diagnosis, risk factors, clinical presentation, prevention, and treatment of cannabinoid hyperemesis syndrome (CHS).

Research on the prevalence, diagnosis, risk factors, prevention, treatment, and outcomes associated with cannabis use disorder, including distinctions among different patterns of cannabis use and populations.

Research examining relationships among chronic pain, cannabis use, medical cannabis access, mental health, suicidal ideation, suicide risk, and other factors that may influence patient outcomes.

Research and reports assessing how medical cannabis, cannabinoids, and the endocannabinoid system are addressed in medical, nursing, pharmacy, and other health-professional education, as well as continuing medical education and clinical training.

Research and clinical guidance addressing practices that may reduce risk, including dosing, titration, routes of administration, onset and duration, storage, impairment, product selection, and communication between patients and healthcare professionals.

Research examining medical cannabis use among patients taking multiple medications, including potential drug interactions, changes in medication use, deprescribing, adverse events, and clinical monitoring.

Research and surveillance data examining cannabis-related emergency department visits, poison-control calls, hospitalizations, adverse reactions, accidental exposures, product-related incidents, and changes in these outcomes over time.

Research examining the endocannabinoid system (ECS), its role in human physiology and homeostasis, relationships with other biological systems, and emerging evidence concerning ECS function, dysfunction, and health.

Research examining how young people obtain cannabis, factors associated with initiation and use, prevention strategies, parental engagement, product access, marketing, storage, and policies intended to reduce unauthorized youth access.

Research examining how cannabis laws and enforcement policies affect young people, including arrests, school discipline, juvenile justice involvement, diversion programs, health outcomes, and unintended consequences of different policy approaches.

Research evaluating age-appropriate cannabis education and prevention strategies, including how messaging, curriculum, parental communication, risk education, and health information should differ across developmental stages.

Research examining relationships among adolescent cannabis use, mental health conditions, self-medication, genetic or family history, age of initiation, frequency of use, potency, and other factors that may influence psychiatric outcomes.

Research on the therapeutic use of cannabis-derived medicines and cannabinoids in pediatric populations, including indications, efficacy, dosing, safety, adverse effects, caregiver considerations, and clinical oversight.

Research examining cannabis-related impairment and driving, including crash risk, measurement of impairment, roadside testing, duration of effects, public education, enforcement strategies, and the limitations of current testing approaches.

Research on unintended cannabis exposure and intoxication, including pediatric exposures, accidental ingestion, dosing errors, packaging, labeling, storage practices, poison-control data, and prevention strategies.

Research examining cannabis use and workplace safety, including impairment, occupational risk, drug testing, disability and medical-use considerations, workplace policies, safety-sensitive positions, and methods for identifying current impairment.

Research examining environmental issues associated with cannabis cultivation, manufacturing, processing, packaging, and disposal, including energy and water use, pesticides, waste, emissions, land use, and approaches to improving environmental sustainability.